Selective screening for GDM in Italy: Application and effectiveness of National Guidelines
Abstract
In September 2011 the Italian Public Health Authority established selective screening for GDM to be performed based on the presence of risk factors. In a cohort of 2552 Caucasian pregnant women we evaluated to which extent the new national guidelines (NGL) are correctly applied; moreover we estimated the prevalence of GDM assessed by NGL. Our data show that the NGL are still properly implemented since the screening test was performed in nearly the totality of the women at 24th and 28th week of gestation. GDM prevalence is 10.9%, 25% greater as compared to the one determined with the old criteria 10 years ago.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Italy, the prevalence of gestational diabetes mellitus was 10.9% and 25% higher than when using the old criteria.
“Their results showed that the prevalence of GDM was 10.9% and 25% higher than when using the old criteria.”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [118]
In Italy, most gestational diabetes mellitus tests were performed between 24 and 28 weeks of gestation, which departs from the new Italian guidelines.
“Additionally, most of the tests were performed between 24 and 28 weeks of gestation, which departs from the new Italian guidelines (between 16 and 18 weeks of gestation in GDM high-risk pregnancies, between 24 and 28 weeks of gestation in medium-risk pregnancies; no OGTT in low-risk pregnancies) [118].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [118]
In 2010 Italy adopted IADPSG/WHO 2013 as universal screening criteria for gestational diabetes mellitus, but in September 2011 the Italian Public Health Authority changed to selective screening because the level of GDM diagnoses was too high using the new criteria.
“In 2010 Italy accepted and adopted the IADPSG/WHO 2013 as the universal screening criteria for GDM, but in September 2011, the Italian Public Health Authority changed the GDM guidelines and decided on selective screening. The reason was due to the fact that the level of GDM diagnoses was too high using the new criteria.”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [118]
Cited by
Sorted by citations
Prevalence of gestational diabetes mellitus in Europe: A meta-analysis
Eades, C. E., Cameron, D. M., & Evans, J. M. M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.030 · Cited by 300 · see citing works
Evolution of Gestational Diabetes Mellitus across Continents in 21st Century
Dłuski, D. F., Ruszała, M., Rudziński, G., Pożarowska, K., Brzuszkiewicz, K., & Leszczyńska-Gorzelak, B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315804 · Cited by 41 · see citing works
Bomba-Opoń, D. A., Godek, B., Czekaj, L., Huras, H., Jakubiec-Wisniewska, K., Janowiec, K., Leszczynska-Gorzelak, B., Slodzinska, M., Zimmer, M., Bek, W., et al. (2022) · Ginekologia Polska · doi:10.5603/gp.a2021.0257 · Cited by 3 · see citing works
- Authors
- Lacaria, E., Lencioni, C., Russo, L., Romano, M., Lemmi, P., Battini, L., Del Prato, S., Bertolotto, A., & Di Cianni, G.
- Affiliations
- University of Pisa (IT)
- Ospedale di Livorno (IT)
- Azienda Ospedaliera Universitaria Pisana (IT)
- ORCID
- Battini, Lorella
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2014-10-17
- Volume
- 28
- Issue
- 15
- Pages
- 1842-1844
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2111785340
- Cited by
- 21
- References
- 0
- Citations by year
- 2026: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 2
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, targeted screening, risk factors, national clinical guidelines, guideline implementation, GDM prevalence, pregnant women
- MeSH terms
- Adult, Female, Glucose Tolerance Test, Humans, Italy, Mass Screening, Pregnancy, Prenatal Diagnosis, Risk Factors, Program Evaluation, Prevalence, Diabetes, Gestational, Practice Guidelines as Topic, Patient Selection, Guideline Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
